David Cornblath is a Neurologist in Lutherville, Maryland. Dr. Cornblath is rated as an Elite provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Chronic Polyradiculoneuritis, Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Dr. Pardo's interest in transverse myelitis centers on management of acute myelitis, biomarkers of the disease in cerebrospinal fluid (CSF) and blood, and the role of neuroimmune factors in the pathogenesis of myelopathies. Along with others neurologists and health care providers in the Johns Hopkins Transverse Myelitis Center, Dr. Pardo focuses on a comprehensive approach in the diagnosis and management of myelopathies, myelitis, neuroimmunological and neuroinfectious disorders. Dr. Pardo is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Acute Flaccid Myelitis (AFM), Neurosarcoidosis, Transverse Myelitis, Zika Virus Disease, and Gastrostomy.

Dr. Brett Morrison specializes in neuromuscular disorders in adults including peripheral neuropathies, amyotrophic lateral sclerosis, myasthenia gravis and muscle diseases. Dr. Morrison is currently the site principal investigator for clinical trials investigating new treatments for chronic inflammatory demyelinating polyneuropathy (CIDP) and painful diabetic peripheral neuropathy. Dr. Morrison's research interests include investigations into the mechanisms of nerve regeneration and common peripheral neuropathies. Current research focuses on better understanding the role of the immune system in peripheral nerves and targeting these pathways for the development of new treatments. Dr. Brett Morrison received his M.D. and Ph.D. from Mount Sinai Medical School in New York City. He completed his medical internship at the University of Maryland and residency in neurology at The Johns Hopkins Hospital. He then completed a fellowship in Clinical Neurophysiology at The Johns Hopkins Hospital. Dr. Morrison is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy (SMA).

Dr. Bipasha Mukherjee-Clavin is an Assistant Professor of Neurology in the Johns Hopkins University School of Medicine. She cares for patients with neuromuscular disorders, with a special focus on patients with peripheral neuropathy, immune-mediated neuropathy, and inherited neuropathy (also known as Charcot-Marie-Tooth disease). She sees patients in the Johns Hopkins Peripheral Nerve and multidisciplinary Charcot-Marie-Tooth clinics, and performs electromyography in the Johns Hopkins EMG lab. As a stem cell biology-trained scientist, Dr. Mukherjee-Clavin's research is focused on the use of patient-derived induced pluripotent stem cells to model genetic Schwann cell and peripheral nerve disorders to undercover novel pathways and potential treatments. During her PhD she published one of the first studies of CMT1A using patient derived stem cells (Comparison of three congruent patient-specific cells types for the modelling of a human genetic Schwann-cell disorder. Nature Biomedical Engineering. volume 3, pages 571–582 (2019)). In 2022, she was awarded the Passano award, given to a promising early career physician-scientist in the Johns Hopkins University School of Medicine. Dr. Mukherjee-Clavin completed her undergraduate studies at the University of California, Berkeley. She then completed her MD/PhD degrees, Neurology residency, and clinical Neuromuscular fellowship in the Johns Hopkins University School of Medicine. She joined the Johns Hopkins Neurology faculty in 2022. Dr. Mukherjee is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. Her top areas of expertise are Charcot-Marie-Tooth Disease, Guillain-Barre Syndrome, Chronic Polyradiculoneuritis, and Miller-Fisher Syndrome.

Dr. R. Samuel Mayer is an associate professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. His clinical interests include complications of critical illness, spine disorders, pain management, disorders of muscle tone and cancer rehabilitation. Dr. Mayer serves as the director of cancer rehabilitation, director of undergraduate medical education and residency program director for the Department of Physical Medicine and Rehabilitation. He graduated from the honors program in medical education at Northwestern University School of Medicine and completed his residency in physical medicine and rehabilitation at Rush Medical College. He was chair of the Committee on Medical Education for the American Medical Student Association while he was a medical student. After completing his residency, he remained on faculty at Rush Medical College, eventually becoming the residency program director and acting chair of the Department of Physical Medicine and Rehabilitation. He joined the Department of Physical Medicine and Rehabilitation at Johns Hopkins in 2001. Dr. Mayer serves as director of the Medical Student Summer Clinical Experience in Physical Medicine and Rehabilitation for the Association of Academic Physiatrists. He is Editor in Chief of Knowledge NOW, the American Academy of Physical Medicine and Rehabilitation's online encyclopedia of the field. In 2014, he was named Distinguished Clinician by the American Academy of Physical Medicine and Rehabilitation. Dr. Mayer is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Pediatric Low-Grade Glioma (pLGG), Hemiplegia, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Mohammad Khoshnoodi is a Neurologist in Baltimore, Maryland. Dr. Khoshnoodi is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Peripheral Neuropathy, Chronic Polyradiculoneuritis, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Dr. Tracy Friedlander is a clinical associate specializing in neurological rehabilitation at the Johns Hopkins Department of Physical Medicine and Rehabilitation. Her focus is on helping patients manage spasticity (a muscle control disorder) through a variety of treatment approaches. Dr. Friedlander graduated from Emory University in Atlanta, GA, and earned her medical degree at the University of Maryland School of Medicine. She interned at Mercy Medical Center and completed her residence in physical medicine and rehabilitation at Sinai Hospital of Baltimore. Videos Dr. Tracy FriedlanderNeurological Rehabilitation Selected Publications Henrikson CA , Howell EE , Bush DE , Miles JS , Meininger GR , Friedlander T , Bushnell AC , Chandra-Strobos N. Prognostic usefulness of marginal troponin T elevation. The American Journal of Cardiology. 2004 Feb; 93(3): 275-279. Henrikson CA , Howell EE , Bush DE , Miles JS, Meininger GR , Friedlander T , Bushnell AC , Chandra-Strobos N. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Annals of Internal Medicine. 2003 Dec; 139(12): 979-986 Courses & Syllabi Inpatient Rehabilitation of Spinal Cord Injury, Johns Hopkins University. Dr. Friedlander is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. Her top areas of expertise are Hemiplegia, Miller-Fisher Syndrome, Guillain-Barre Syndrome, and Spasticity.

Dr. Michael Polydefkis focuses on neuromuscular diseases, particularly peripheral nerve diseases. He has a special interest in diabetic and HIV-associated peripheral neuropathy. His expertise includes nerve conduction studies, electromyography and nerve, skin and muscle biopsy reading. Dr. Michael Polydefkis received his medical degree from The Johns Hopkins University School of Medicine. He then became a Howard Hughes Medical Institute research fellow before returning to Johns Hopkins to complete an internship and residency in internal medicine, residency in neurology and a fellowship in neuromuscular diseases. Dr. Polydefkis is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Primary Amyloidosis, and Peripheral Neuropathy.

Neurologist Susanne Muehlschlegel is an internationally known clinician-researcher who specializes in critically ill patients as well as understanding and improving shared decision-making and the ways physicians derive and convey health care recommendations and prognostication to families of neuro-critically ill patients. Her empirical family- and patient-centered research intersects with decision-science, qualitative and mixed-methods research, neurology, neurosurgery, and critical care medicine. She strongly believes that involving families and other stakeholders in her research will positively impact the clinical care of neurocritically ill patients. More about her research: Muehlschlegel Lab Dr. Muehlschlegel earned her medical degree at Philipps-University in Marburg, Germany. She completed an internship in internal medicine followed by residency training at Shands Hospital and Malcolm Randall Veteran Affairs Medical Center at the University of Florida College of Medicine. She finished her fellowship training in neurocritical care at the Harvard Combined Program at Massachusetts General Hospital and Brigham and Women’s Hospital, and she obtained her master’s degree in public health at the Harvard School of Public Health. She is the co-chair of a large international guideline on neuroprognostication, a joint guideline between the Neurocritical Care Society and the German Society for Neuro-Intensive Care Medicine (Deutsche Gesellschaft für Neurointensivmedizin). She served as the leader of the “Curing Coma” Common Data Elements subgroup for “Goals of Care Decisions / Family Data” with national and international group members. She also served as co-chair of the NIH/NINDS-funded Family Experience Workshop after Cardiac Arrest and Severe Neurotrauma. Dr. Muehlschlegel is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. Her top areas of expertise are Traumatic Brain Injury, Subarachnoid Hemorrhage, Stroke, Craniectomy, and Gastrostomy.

Alba Azola, M.D., is a rehabilitation physician helping patients restore function and movement after an injury or illness. Her expertise includes neurorehabilitation and rehabilitation for swallowing disorders. Dr. Azola completed her residency in physical medicine and rehabilitation at the Johns Hopkins Department of Physical Medicine and Rehabilitation, where in her final year she was awarded the Frank L. Coulson, Jr. Award for Clinical Excellence. Prior to the residency, she was a post-doctoral fellow at the Swallowing Neurophysiology Laboratory at Johns Hopkins. Dr. Azola received her medical degree from the Ponce School of Medicine in Puerto Rico, where she grew up. After the devastating hurricane Maria in 2017, she returned to her homeland to help with hurricane relief. Dr. Azola is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. Her top areas of expertise are Miller-Fisher Syndrome, Guillain-Barre Syndrome, Stroke, Endoscopy, and Gastric Bypass.

Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy.

Arens Taga is a neurologist specializing in neuromuscular diseases, with a particular focus on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. His clinical work aims to improve the quality of care for patients with ALS through biomarker-based, precision medicine approaches that refine disease stratification and facilitate more targeted and efficient enrollment in clinical trials. As a clinician-scientist, Dr. Taga uses patient-derived induced pluripotent stem cells to model ALS, uncover novel disease mechanisms and identify therapeutic targets that are translatable to clinical trials. In recognition of his work in ALS, Dr. Taga was awarded the 2025 Richard Olney Clinician Scientist Development Award, which honors early-career physician-scientists dedicated to advancing ALS research. Dr. Taga earned his medical degree from the School of Medicine and Surgery at the University of Parma, Italy, where he also completed his neurology residency. He subsequently trained at The Johns Hopkins University, completing a postdoctoral research fellowship in the neuromuscular division, an internal medicine internship, a neurology residency and a neuromuscular clinical fellowship. Dr. Taga is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Cluster Headache.

Daniel Krasna, M.D., is a fellowship-trained Brain Injury Medicine physician in the Department of Physical Medicine and Rehabilitation. He specializes in treating patients who have had a brain injury regardless of the cause including trauma, spontaneous bleed, and lack of oxygen. This includes helping manage their behaviors, guiding their therapies, and providing interventions for spasticity. He completed his residency at Schwab Rehabilitation / University of Chicago in Illinois and his Brain Injury fellowship at Moss Rehabilitation/ Einstein Healthcare in Elkins Park, PA. Dr. Krasna is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Stroke, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Nicholas Maragakis treats patients with motor neuron diseases, such as amyotrophic lateral sclerosis (ALS). This care is coordinated with the Johns Hopkins Center for ALS Specialty Care, a multidisciplinary clinic with expertise in treating patients with ALS and providing support to their caregivers. He serves as medical director of the ALS Clinical Trials Unit, an extension of the multidisciplinary clinic that seeks to facilitate opportunities for patients with ALS to participate in clinical trials that could advance the treatment of this disease. Dr. Maragakis is interested in the basic science of understanding neurodegenerative diseases, as well as the translational potential of therapeutic compounds developed in the laboratory. His fundamental research interest is in using stem cells — more specifically, stem cell-derived motor neurons and glia — for understanding the development and propagation of ALS. His laboratory has been involved in creating and characterizing lines of stem cells from patients with ALS using induced pluripotent stem cell (iPSC) methodologies. The laboratory has a large library of iPSCs from patients with familial ALS and from patients with sporadic ALS. The utilization of this library of iPSCs has facilitated the development of a spinal cord-specific iPSC-astrocyte/motor neuron co-culture system, which has been leveraged for the development of assays that can be used for both the basic understanding of ALS astrocyte and motor neuron biology as well as, eventually, drug screening for ALS therapeutics. His laboratory has taken its long-standing interests in astrocyte biology, as it relates to ALS, to develop a program that investigates astrocyte-specific mechanisms as contributors to the progression (both temporally and anatomically) of disease in ALS. In this vein, there is an interest in astrocytic glutamate transporters and, more recently, astrocyte hemichannels and gap junctions. Dr. Maragakis is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, 15q11.2 Microdeletion, and Spinal Muscular Atrophy (SMA).

Dr. Justin McArthur is nationally and internationally recognized for his work in studying the natural history, development and treatment of the neurological complications of HIV/AIDS, multiple sclerosis and other neurological infections and immune-mediated neurological disorders. Dr. McArthur has also developed a technique to use cutaneous nerves to study sensory neuropathies, including those associated with chemotherapy, HIV and diabetes. Currently his clinical practice includes neuroimmunological disorders including MS, neurological infections, and complex undiagnosed neurological disorders. Dr. McArthur was the founding director of the Johns Hopkins/National Institute of Mental Health Research Center for HIV-associated Cognitive Disorders. The Center is an experienced interdisciplinary research team who have pooled their talents to study the nature of HIV-associated cognitive disorders. he is also the founding director of the Johns Hopkins Sheikh Khalifa Stroke institute. Dr. McArthur received his medical degree from Guys Hospital Medical School in London, UK. He then completed an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, MD. Dr. McArthur stayed with Johns Hopkins to complete a residency in neurology and achieve his Master's in public health. He is the current Director of the Johns Hopkins Department of Neurology and holds the John W. Griffin Professorship in neurology which was established in 2015 by Jeffrey and Harriet Legum. In April 2017 Dr. McArthur was elected to the Association of American Physicians. In 2020 he was inducted into the National Academy of Medicine. Dr. Mcarthur is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Progressive Multifocal Leukoencephalopathy, Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), and Encephalitis.

Neil Porter is a Neurologist in Baltimore, Maryland. Dr. Porter is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Myasthenia Gravis, Mononeuritis Multiplex, Multiple Mononeuropathy, Riboflavin Transporter Deficiency Neuronopathy, and Gastrostomy.

Vinay Chaudhry is a Neurologist in Baltimore, Maryland. Dr. Chaudhry is rated as an Advanced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myasthenia Gravis, Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Advanced Bronchoscopy.

Dr. David Hale is a fellowship-trained neurologist specializing in neuro-visual and vestibular disorders. He diagnoses and treats patients with symptoms including dizziness, vertigo, oscillopsia, double vision and imbalance. Dr. Hale’s patient evaluations include vestibular testing. Dr. Hale earned his medical degree at Pennsylvania State University and completed a neurology residency at the Johns Hopkins University School of Medicine. He remained at Johns Hopkins for fellowship training in vestibular and ocular-motor oto-neurology. Dr. Hale is interested in resident and fellow medical education, specifically the development of ways to make knowledge of subspecialist neurologists more accessible to those in training. He serves as the co-director of the Vestibular and Ocular-Motor Oto-Neurology Clinical Fellowship at Johns Hopkins. Dr. Hale is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Vertigo, Chronic Polyradiculoneuritis, Miller-Fisher Syndrome, and Guillain-Barre Syndrome.

Dr. Abhay Moghekar focuses on disorders of cerebrospinal fluid physiology like normal pressure hydrocephalus, obstructive hydrocephalus, congenital hydrocephalus, pseudotumor cerebri, CSF otorhhea, CSF rhinorrhea, intracranial hypotension due to spinal CSF leaks and peri-operative management of patients undergoing repair of CSF otorrhea and rhinorrhea. His research interests include identifying biomarkers of neurodegenerative disorders including Alzheimer's disease and Normal Pressure Hydrocephalus. Dr. Moghekar is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Increased Intracranial Pressure, Hydrocephalus, Pseudotumor Cerebri Syndrome, Stent Placement, and Gastrostomy.

Laura Black is a Physiatrist and a Pediatrics provider in Baltimore, Maryland. Dr. Black is rated as an Experienced provider by MediFind in the treatment of Guillain-Barre Syndrome. Her top areas of expertise are Cerebral Palsy, Spastic Diplegia Infantile Type, Chondrodysplasia Punctata with Steroid Sulfatase Deficiency, and Recessive Chondrodysplasia Punctata 1.